Lenalidomide in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia with Chromosome 5 Abnormalities
(2009) 51st Annual Meeting of the American-Society-of-Hematology In Blood 114(22). p.52-52
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1616115
- author
- organization
- publishing date
- 2009
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Blood
- volume
- 114
- issue
- 22
- pages
- 52 - 52
- publisher
- American Society of Hematology
- conference name
- 51st Annual Meeting of the American-Society-of-Hematology
- conference dates
- 2009-12-05 - 2009-12-08
- external identifiers
-
- wos:000272725800116
- ISSN
- 1528-0020
- language
- English
- LU publication?
- yes
- additional info
- The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Hematopoietic Stem Cell Laboratory (013022012)
- id
- c6eabfe1-aafd-4261-a5bf-e1ba5310381b (old id 1616115)
- date added to LUP
- 2016-04-01 12:28:28
- date last changed
- 2018-11-21 20:07:47
@misc{c6eabfe1-aafd-4261-a5bf-e1ba5310381b, author = {{Mollgard, Lars and Nilsson, Lars and Kjeldsen, Lars and Dybedal, Ingunn and Dufva, Inge Hogh and Garelius, Hege and Norgaard, Jan Maxwell and Linder, Olle and Ejerblad, Elisabeth and Astermark, Jan and Hellstrom-Lindberg, Eva}}, issn = {{1528-0020}}, language = {{eng}}, note = {{Conference Abstract}}, number = {{22}}, pages = {{52--52}}, publisher = {{American Society of Hematology}}, series = {{Blood}}, title = {{Lenalidomide in High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia with Chromosome 5 Abnormalities}}, volume = {{114}}, year = {{2009}}, }